Proposed Combination Product Rules Tackle GMPs, Adverse Events
This article was originally published in The Silver Sheet
Executive Summary
TWO PROPOSED RULES FOR COMBO PRODUCT FIRMS focus on "streamlined" GMP and post-market surveillance requirements for manufacturers. FDA is also working on a companion guidance, which will be released when the combination product GMP rule is finalized